Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Please note that this position can be based in Princeton, NJ. Acadia's hybrid model requires this role to work in our office three days per week on average. Position Summary The Director, Formulation Development leads formulation, primary packaging, and manufacturing process development across Acadia’s portfolio of drug candidates from early development through commercialization. This role provides technical leadership for externalized drug product development across oral solid, liquid, and injectable dosage forms, with a primary focus on oral solid dosage forms. The position is responsible for managing Contract Service Providers (CSPs), resolving complex technical issues, and advancing manufacturing process technologies that support clinical supply, process validation, and lifecycle management. This role plays a key part in reducing development risk, improving execution, and accelerating program progression.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director